Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Cancer
    • Apollo Hospitals...

    Apollo Hospitals organizes 1st International PROTON Therapy Educational Programme

    Written by Hina Zahid Published On 2018-11-12T19:05:03+05:30  |  Updated On 12 Nov 2018 7:05 PM IST
    Apollo Hospitals organizes 1st International PROTON Therapy Educational Programme

    • Global oncology specialists come together to share insights on cancer care through PROTON beam therapy
    • Delegates tour the soon-to-be-launched state-of-the-art Apollo Proton Cancer Centre facility, South East Asia’s first Proton Therapy Centre


    New Delhi: Over 400 delegates from across India and Asia gathered at the 1st International PROTON Therapy Educational Programme organized jointly by Particle Therapy Cooperative Group (PTCOG) and Apollo Proton Cancer Centre (APCC). Proton Therapy is the most advanced and targeted cancer treatment due to its superior dose distribution and minimal side effects that helps treat cancer more effectively and efficiently. The two days long comprehensive interactive scientific programme saw specialists from Austria, Denmark, India, Sweden, Switzerland, and the US sharing their knowledge on various aspects of Proton therapy technology and treatment, to give a comprehensive overview of the application in clinical practice. The prestigious conference saw the Health Ministers from South Africa, Oman, Yemen and Sri Lanka in attendance.


    Inaugurated by Dr. Motosoahae Thomas Thabane, Hon. Prime Minister of Lesotho, the conference included plenary talks from internationally recognized experts in Proton Therapy, and value-adding educational sessions providing a comprehensive overview of the technology and clinical practices related to particle therapy from its origin to current day modern technologies. The highlight was a tour of the soon-to-be-launched state-of-the-art Apollo Proton Cancer Centre that had the delegates expressing their appreciation of the modern comprehensive facilities for organ-specific cancer management.



    Dr Preetha Reddy, Vice Chairperson, Apollo Hospitals said, “The 1st International PROTON Therapy Educational Programme will help physicians and oncologists understand the potential of this new technology to treat cancer. With the cancer burden in India increasing day by day, we are glad to be at the forefront in taking up the challenge of providing the best treatment option available in the world. In continuation of this legacy, we are launching this Proton therapy facility, which will be the first in South East Asia and a major milestone in our concerted focus to battle and conquer cancer.”


    Speaking at the conference, Mr. Harshad Reddy, Apollo Proton Cancer Centre said, “The Apollo Proton Cancer Centre is our bulwark in the battle against cancer! It is important to build the right understanding and application of this treatment in cancer. We are happy for the opportunity to host this two-day conference with PTCOG and APCC have jointly come together to organize this two-day educational programme that offers clinical and technical understanding of PROTON treatment.”


    Standard radiation therapy comprises of X-ray beams that deposit their energy along the path of the beam, to a tumour and beyond, resulting in radiation being delivered not only to a tumour but also to the healthy tissues around a tumour. This causes damage to the normal tissue or organs near a tumour. With proton therapy, it is possible to control the location of the release of the energy and precisely target a tumour, causing the most damage to the targeted tumour cells, while sparing healthy tissues and organs. A proton beam is just millimeters wide and allows the effective treatment of complex tumours in the eye, brain, prostate, as well as cancers in children with the advantage that healthy tissue and critical organs are not harmed. It gives the patient a better quality of life during and after treatment.


    Dr Rakesh Jalali, Medical Director, Apollo Proton Cancer Centre said, “Cancer treatment has been phenomenally transformed due to Proton Therapy. It helps in treating tumors located especially in difficult to access areas such as in head, neck, pancreas, and prostate. It is most effective considering the possibility of giving higher doses of radiation to control and manage cancer while reducing damage to vital organs and healthy tissues. The scientific and knowledge sessions in the 1st International PROTON Therapy Educational Programme have made the delegates aware of the added value of Proton beam therapy in cancer treatment.”

    cancer caredenmarkDr Motosoahae Thomas ThabaneDr Preetha ReddyDr Rakesh JalaliJay FlanzMr Harshad Reddynew delhiParticle Therapy Cooperative Groupphenomenally transformedProton therapyProton Therapy Centretumourtumour cellsX ray
    Source : Press Release

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Hina Zahid
    Hina Zahid
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok